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Abstract
Background: Chronic neck pain is highly prevalent in Western societies, with about 15% of
females and 10% of males suffering with it at any time. The course of untreated chronic neck pain
patients in clinical trials has not been well-defined and the placebo effect has not been clarified.
Methods: A systematic review of RCT's of conservative treatments for chronic mechanical neck
pain was conducted. Studies were excluded if they did not include a control group, if they involved
subjects with whiplash injuries, a predominance of headache or arm pain associated with chronic
neck pain and if only one treatment was reported. Only studies scoring 3–5 out of 5 on the Jadad
Scale for quality were included in the final analysis. Data on change in pain scores of subjects in both
placebo (PL) as well as no-treatment (NT) control groups were analyzed. Mean changes in pain
scores as well as effect sizes were calculated, summarized and compared between these groups.
Results: Twenty (20) studies, 5 in the NT group and 15 in the PL group, with outcome intervals
ranging from 1–52 weeks were included in the final analysis. The mean [95% CI] effect size of
change in pain ratings in the no-treatment control studies at outcome points up to 10 weeks was
0.18 [-0.05, 0.41] and for outcomes from 12–52 weeks it was 0.4 [0.12, 0.68]. In the placebo control
groups it was 0.50 [0.10, 0.90] at up to 10 weeks and 0.33. [-1.97, 2.66] at 12–24 weeks. None of
the comparisons between the no-treatment and placebo groups were statistically significant.
Conclusion: It appears that the changes in pain scores in subjects with chronic neck pain not due
to whiplash who are enrolled in no-treatment and placebo control groups were similarly small and
not significantly different. As well, they do not appear to increase over longer-term follow-up.
Background
Neck pain is a very common problem, second only to low
back pain in its frequency in the general population [1-3]
and in musculoskeletal practice [4]. Estimates of the prev-
alence of chronic neck pain vary. In a Swedish population
[5] 18.5% of females and 13.2% of males had neck pain
for longer than 6 months; however, when continuous
chronicity was rated, these figures were reduced to 10%
and 7%, respectively. A Finnish study [6] reported chronic
neck pain in 13.5% of females and 9.5% of males. A Nor-
wegian study [7] reported an overall rate of 13.8% for
neck pain greater than 6 months duration; however, for
sub-groups above the age of 43, the rate rose above 20%.
It would appear that about 15% of females and 10% of
men suffer with chronic neck pain at any given time.
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Clinical researchers are interested in the following ques-
tion as it relates to chronic neck pain: "in a clinical trial,
what is the expected outcome of chronic mechanical neck
pain patients who are assigned to control groups?" Specif-
ically, it would be useful to know the average magnitudes
of change in various clinically important parameters such
as pain and disability status at, for example, one, three, six
and twelve months, in order to track the course of the con-
dition in the absence of any formal treatment. Surpris-
ingly, this question has received little attention in the
literature.
As noted above, numerous studies exist which provide
information on the prevalence of chronic neck pain in
general and specific (i.e., occupational) populations and
typically report these as one-week, one-month, six-
month, annual or lifetime occurrences [1-11]. However,
the clinical course of these types of patients in the absence
of any formal treatment has not been studied so thor-
oughly. Recently, Borghouts et al. [12] reviewed a selected
group of observational studies (with no treatment pro-
vided) [13-19] as well as randomized clinical trials
(RCT's) which provided information on the clinical
course or prognosis of chronic neck pain. They remarked
that the body of reports they reviewed had numerous defi-
ciencies. They summarized these studies as follows:
"...within six months, approximately 50% of patients had
less pain and a general improvement of 50%, with a mean
reduction of pain and use of analgesics of about 30%"
[[12], pg.12].
We have used Borghouts et al.'s study as a foundation for
an expanded review of the issue of the response of chronic
mechanical neck pain patients in clinical trials who do not
receive any formal treatment. It is recognized that data
obtained from controlled clinical trial reports would not
be truly observational, in that subjects in control groups
are highly selected for inclusion. As well, they may benefit
from the mere fact that they participated in a clinical trial;
however, at least this effect would not be confounded by
any formal intervention (although, see Discussion, re:
self-treatments).
Two types of control groups exist for this purpose: no-
treatment (NT) controls and placebo (PL) controls. Each
of these groups has advantages and disadvantages with
respect to a determination of clinical outcome or course.
For no-treatment controls, a so-called "trial effect" (non-
specific effect) would exist resulting from the basic fact of
selection for and participation in a clinical trial; however,
since subjects would be aware of their status as "not
receiving treatment", the positive "trial effect" might be
counteracted (nocebo effect), making their outcomes an
approximation of the "natural history" of chronic neck
pain over the duration of the study and any follow-up
intervals. In Borghouts' et al. review of 17 RCT's, 3 trials
had no-treatment control groups [20-22]; however, the
authors do not summarize the outcomes of these studies
specifically.
The outcomes of placebo control groups would not con-
stitute the "natural history" of the chronic neck pain, as,
in these circumstances, subjects are lead to believe that
they are receiving a true treatment [23,24]. Data from pla-
cebo groups actually answers the question, "what is the
expected outcome over a certain period of time when a
person (or a group of similar persons) believes they are
receiving true treatment, when, in fact, they are not?" In
Borghouts et al., 6 trials are reviewed with placebo con-
trols [25-30], but they, too, were not summarized with
respect to this question.
Current experimental theory [23,24] would suggest that
the magnitudes of positive change in outcomes of placebo
control groups would exceed those of the non-treatment
control groups. To our knowledge, however, a systematic
analysis of change scores of pain measurements in these
control groups of chronic neck pain patients has not spe-
cifically been conducted. We report here on a systematic
review of conservative intervention studies for chronic
mechanical neck pain that have employed either no-treat-
ment or placebo control groups and which provide data
which can be applied to the second and third methodolo-
gies described above. Thus, we present data from a group
of controlled RCT's for chronic neck pain in order to bet-
ter determine the magnitude of clinical change in chronic
mechanical neck pain patients enrolled in clinical trials. It
is expected that this will provide as estimate of the placebo
effect in these subjects as well as provide useful input for
future sample size calculations in this area.
Methods
A comprehensive literature search was performed in
MEDLINE, CINHAHL, AMED, MANTIS, Index to Chiro-
practic Literature, Alt HealthWatch, the Cochrane Data-
base of Systematic Reviews, the Cochrane Controlled
Trials Registry, and several EBSCO Information Services
databases (Biomedical Reference Collection, Nursing and
Allied Health Collection, Psychological and Behavioural
Sciences Collection) using the strategy outlined in Table
1.
Citation searches were also conducted manually. The lim-
itation to English was based on the inability to translate
any non-English studies.
Selections were then made according to the criteria
described below. Inclusion: the study design was a rand-
omized clinical trial of conservative or complementaryBMC Musculoskeletal Disorders 2006, 7:58 http://www.biomedcentral.com/1471-2474/7/58
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therapies for chronic neck pain. As several studies
employed time frames for pain duration less than the con-
ventional interval of 12 weeks, and as we sought the larg-
est sample possible, we defined "chronic neck pain" as
neck pain of longer than eight weeks in duration [31].
Only studies with control groups designated as "no-treat-
ment" (NT) or "placebo" (PL) were included. Exclusion:
studies involving subjects with a predominance of radicu-
lar pain, osteoarthritis of the neck, or headaches were
excluded; studies involving subjects with neck and back
pain, where the data related to neck pain could not be
extracted, were excluded; studies employing exclusively
surgery were excluded.
Studies qualifying according to the above criteria were
then assessed for quality using the Jadad Scale [32]. The
Jadad scale is a 5-point scale which is one of the oldest
[32], most well-validated [33,34] and reliable [35] scales
for assessing the quality of randomized clinical trials.
Studies scoring 3 – 5 out of 5 were accepted.
Data on pain outcomes of the control groups were
extracted from each study. Most studies employed a 100
mm visual analogue scale (VAS) to measure pain ratings
and reported these as mean (SD) values at baseline and at
various outcomes points thereafter. Some trials reported
the median values of this outcome. Mean (95%CI) or
median values for pain scores were abstracted. Baseline
pain scores were averaged and compared between the NT
and PL groups with a Student's t-test. Absolute and rela-
tive change scores were calculated in mm of a pain visual
analogue scale (VAS) and percentages, respectively. These
were also compared between the NT and PL groups with a
Student's t-test for assumed unequal variances. Effect sizes
Table 1: Search Strategy
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.
3 randomized controlled trials.sh.
4 random allocation.sh.
5 double blind method.sh.
6 single blind method.sh.
7 1 or 2 or 3 or 4 or 5 or 6
8 clinical trial.pt.
9 exp clinical trials/
10 (clin$ adj trial$).ti, ab.
11 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti, ab.
12 placebos.sh.
13 Placebo$.ti, ab.
14 random$.ti, ab.
15 Research design.sh.
16 or/8–15
17 comparative study.sh.
18 exp evaluation studies/
19 follow up studies.sh.
20 prospective studies.sh.
21 (control$ or prospective$ or volunteer$).ti, ab.
22 or/17–21
23 7 or 16 or 22
24 neck pain.mp. or exp Neck Pain/
25 exp CERVICAL VERTEBRAE/
26 24 or 25
27 exp alternative medicine/
28 exp plants, medicinal/
29 exp plant oils/
30 exp plant extracts/
31 exp formularies, homeopathic/
32 ((complementary or unconventional or folk or alternative) adj (med$ or ther$ or treat$ or care)).ti, ab.
33 exp holistic health/
34 exp Physical Therapy Techniques/
35 (physical ther$ or physiother$).ti, ab.
36 exp osteopathy/or exp osteopathic medicine/
37 (chiropract$ or naturopath$ or osteopath$ or homeopath$ or acupunct$).ti, ab.
38 or/27–37
39 23 and 26 and 38
40 limit 39 to english languageB
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Table 2: No-Treatment Control Studies
STUDY CONTROL 
TREATMENT
SAMPLE SIZE 
OF CONTROL 
GROUP
BASELINE 
PAIN VAS 
SCORE 
[mean(sd)/100 
mm]
OUTCOME 
INTERVAL
ABSOLUTE 
CHANGE (mm 
on VAS)*
RELATIVE 
CHANGE (%)
EFFECT SIZE QUALITY 
SCORE (Jadad 
Scale out of 5)
Chiu et al., 2004 [58] Infrared therapy 
and advice
78 43 (21) 6 weeks
6 months
-5
-4
-11.7%
-10.1%
.22
.17
3.5
Waling et al., 2000 [40] Education sessions 
for 2 hr, 1/week 
for 10 weeks
21 32 (23) 10 weeks -2 -6.2 .08 3
Viljanen et al., 2003 [43] No treatment 130 41 (22) 12 weeks
24 weeks
52 weeks
-14
-12
-9
-34.1
-29.2
-21.9
.59
.48
.38
3
Taimela et al., 2000 [41] No formal 
treatment
26 59.9 (19.6) 12 weeks
52 weeks
-20.9
not given
-33%
undet.
undet
undet
3
Lundblad et al., 1999 [58] No treatment 23 Usual pain = 20 
(14)
Worst pain = 55 
(28)
6 weeks
usual:
worst:
-9
-7
-45
-13
.64
.25
3
TOTAL/AVERAGE 278 46.2 For 1–10 wk = -
5.7 [-8.6, -2.8] mm
For 12–52 wk = -
11.9 [-17.4, -6.4] 
mm
For 1–10 wk = -
10.3% [-14.4, -6.2]]
For 12–52 wk = -
25.7% [-34.3, -
17.1]
For 1–10 wk = .18 
[-0.05, 0.41]
For 12–52 wk = .4 
[0.12, 0.68]
Caption: sd = standard deviation; undet = undeterminedBMC Musculoskeletal Disorders 2006, 7:58 http://www.biomedcentral.com/1471-2474/7/58
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were calculated when the data were expressed as means
(95%CI). Effect size was calculated as the difference
between pre- and post-intervention means (for each con-
trol group) divided by the pooled standard deviation
[36,37].
Results
The literature search retrieved 1,980 studies, 30 of which
met our initial inclusion criteria. After quality ratings, 10
of these were rejected (NT controls = 4 [21,22,39,42], PL
controls = 6 [20,27,38,44,48,56]). Twenty studies, 5 in the
NT group [40,41,43,57,58] and 15 in the PL group [28-
30,46,47,49-55,59-61], were included in our final selec-
tion. In this set of studies, the comparison treatments were
acupuncture (n = 4), exercise therapy (n = 5), laser therapy
(n = 5) electrotherapy (n = 3), magnetic necklace (n = 1),
massage (n = 1) and botox injection (n = 1). No study
employing strictly medication(s) was found that met our
criteria for inclusion with respect to the appropriate clini-
cal characteristics.
Five studies were identified from the search which
employed NT control groups [40,41,43,57,58]. In three of
these studies, the control condition consisted of no for-
mal intervention at all [41,43,57]. One study used low-
level education in the form of informal sessions, once
weekly for ten weeks [40]. Finally, one study [58] used
minimal infrared therapy and advice. The average age of
subjects in this group was 41.2 years. The average baseline
pain score was 46.2 mm/100.
The outcome intervals range from 6–52 weeks. Table 2
presents the changes in pain scores of five of the studies
with NT controls. Three studies provided data for 1–10
weeks; 2 studies provided data from 12–52 weeks.
The 1–10-week outcomes are summarized as follows: the
mean (95%CI) absolute change in VAS mm was -5.7 [-8.6,
-2.8] mm; the mean (95%CI) relative change in VAS mm
was -10.3% [-14.4, -6.2]; the mean [95%CI] effect size of
these changes was 0.18 [-0.05, 0.41].
The 12–52 week outcomes are summarized as follows: the
mean absolute change in VAS mm was -11.9 [-17.4, -6.4];
the mean relative change in VAS mm was -25.7% [-34.3, -
17.1]; the mean [95% CI] effect size of these changes was
0.4 [0.12, 0.68].
One study provided data on self-rated improvement (% of
subjects who rated full improvement). Taimela et al. [41],
reported a figure of 23% at 12 weeks and 30% at 52 weeks.
Table 3 presents the results of 14 studies of chronic neck
pain patients from the search which employed a PL con-
trol group (Lewith and Machin, [46] is not included as it
did not report pain scores). All but two of these studies
employed placebo versions of acupuncture or electro-
physiological therapies such as laser, infra-red and electro-
magnetic therapies. Hong et al. [60] employed a placebo
version of a magnetic necklace while Wheeler et al. [61]
employed a single placebo injection into the cervical par-
aspinal muscles. Rigato et al. [47], divided the subjects
into severity categories of mild, moderate and severe, thus
producing three separate outcome comparisons for their
single placebo group. Lewith and Machin [46] did not
provide mean pre-post-intervention outcome scores;
rather, they reported on post-treatment self-rated
improvement (See Table 3). The average age of the sub-
jects in this group was 43.9. One study [49] involved older
patients (average age = 61) who had cervical osteoarthri-
tis. The average baseline pain score in the PL groups was
56.6 mm/100.
The majority of these comparisons were made at between
2–6 weeks post-baseline. Four (4) studies measured out-
comes past 10 weeks [28,51,59,61]. At the outcome point
up to 10 weeks, in 14 studies, the PL groups showed a
mean change of -5.0 mm [-8.1, -1.9] on a 100 mm pain
VAS. None showed a mean change larger than 20 mm.
The mean relative change was -10.6% [-16.4, -4.8]. The
mean [95% CI] effect size in this group of studies was 0.5
[0.10, 0.90].
Four (4) studies [28,51,59,61] provided outcomes from
12–24 weeks. The mean absolute change was -6.7 [-18.6,
5.2] mm and the mean relative change was -8.3% [-32.4,
15.8]. The mean [95%CI] effect size in this group of stud-
ies was 0.33 [-1.97, 2.66].
Lewith and Machin [46] reported that 33% of their pla-
cebo group rated their level of improvement as "good".
This resulted from a change of 2 or more points on a 7-
point pain scale (i.e., greater than 29% improvement in
self-rated pain). It is not possible to compare this finding
with the mean change scores of the other studies. The
finding, in Sator-Katzenschlager et al. [50] of an effect size
of 5.3 after six weeks was considered an anomaly in this
data set, and was to result from very low standard devia-
tions amongst all of their groups as well as a small sample
size in the control group. The findings of Wheeler et al.
[61] were also considered an anomaly in this data set due,
as well, to a small sample size. The placebo effect of injec-
tion therapies may be distinct from those not employing
such interventions. The effect sizes from Wheeler et al.
were not included in the calculation of mean effect size.
Between group comparisons
The baseline pain scores in the PL group were statistically
significantly greater than those in the NT group (39.18B
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Table 3: Placebo-control studies
STUDY CONTROL 
TREATMENT
SAMPLE 
SIZE OF 
CONTROL 
GROUP
BASELINE PAIN 
VAS SCORE 
[mean(sd) or 
median/100 mm]
OUTCOME 
INTERVAL
ABSOLUTE 
CHANGE (mm on 
VAS)*
RELATIVE 
CHANGE (%)
EFFECT 
SIZE
QUALITY 
SCORE 
(Jadad Scale 
out of 5)
Trock et al., 1994 [49] Placebo EMT, 3–5/
week for four weeks
29 62.3 (24.16) 2 weeks
4 weeks
8 weeks
-12
-16.3
-14.7
-19
-26
-24
.44
.67
.54
5
Sator-Katzensch-lager et al., 2003 [50] Control auricular 
acupuncture, 1 Tx per 
week for 6 weeks
11 71 (3) 6 weeks
10 weeks
-16
-4
-22
-5
5.3*
.99
5
Gur et al., 2004 [59] Placebo laser, 10 
treatments in 2 weeks
26 72 (2.52) 2 weeks
3 weeks
12 weeks
-5.7
-11.7
+.04
-8
-16
+1
.14
.26
+.01
4.5
Rigato et al., 2002 [47] Placebo 
electrotherapy daily 
for 15 days
50 High = 80
Med = 48
Low = 36 (no sd's)
7,15 & 45 
days
At 7 days
High = 0
Med = 0
Low = -8
At 15 days
High = 0
Med = 0
Low = 0
At 45 days
High = 0
Med = +2
Low = +2
At 7 days
High = 0
Med = 0
Low = -22
At 15 days
High = 0
Med = 0
Low = 0
At 45 days
High = 0
Med = +4
Low = +6
4
Snyder-Mackler et al., 1989 [52] Placebo laser, 3 Tx 
over 9 days
11 55 (no sd) 9 days -3 -5 4
Foley-Nolan et al., 1990 [29] Placebo EMT for 3 
weeks
10 67.5 (median) 3 weeks -12.5 -19 4
Hong et al., 1982 [60] Non-magnetic 
necklace for 3 weeks
25 71 (14) [converted from 
4-point scale]
3 weeks -7 -10 .05 4
Thorsen et al., 1992 [30] Placebo laser, 6 Tx 
over 2 weeks; then, 
cross-over
47 21 (median) 3 weeks -10 -48 3.5
Wheeler et al., 1998 [61] 1–2 botox injections 11 65 (5) [NPDS/100*] 3 weeks
16 weeks
-16
-21
-24.6
-32.2
2.2*
2.6*
3
Ceccherelli et al., 1989 [28] Placebo laser for 12 
Tx over 24 days
14 29.2 (12.6) 4 weeks
12 weeks
+8.2
+6.4
+28
+22
-.56
-.40
3
Nabeta and Kawakita, 2002 [54] Sham acupuncture, 3 
Tx over 3 weeks
17 48.8 (27.9) 4 weeks -2 -4 .07 3
Irnich et al., 2001 [55] Sham laser 
acupuncture, 5 Tx 
over 3 weeks
57 57.15 (26.71) 4 weeks -17.28 [10–24.6] -30 3
He et al., 2004 [51] Sham acupuncture, 10 
Tx over 4 weeks
12 48 (9) 4 weeks
24 weeks
-12.1
-12.1
-24
-24
1.4
1.4
3
Ozdemir et al., 2001 [53] Placebo laser, daily 
for 10 days
30 73 (14) 10 days -5 -7 .04 3
TOTAL/AVERAGE 350 56.6 For 0–10 weeks = -5.0 
[-8.1, -1.9] mm
For 12–24 weeks = -
6.7 [-18.6, 5.2] mm
For 0–10 weeks = 
-10.6% [-16.4, -
4.8]
For 12–24 weeks 
= -8.3% [-32.4, 
15.8]
For 1–10 
weeks = .50 
[0.10, 0.9]
For 12–24 
weeks = .33 [-
1.97, 2.6]
Caption:
wk = week; Tx = treatment; EMT = electromagnetic therapy; TENS = transcutaneous electrical nerve stimulation; * = not included in analysisBMC Musculoskeletal Disorders 2006, 7:58 http://www.biomedcentral.com/1471-2474/7/58
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{6.6} vs 56.4 {4.3}; t (for unequal variances) = -3.29, p =
.005).
Comparisons of the change scores between the two
groups (PL vs NT) at 0–10 weeks and at greater than 10
weeks for absolute (mm) or relative (%) change showed
no significant differences in any of the four comparisons.
Discussion
There are several ways to interpret the results of this anal-
ysis. The average effect size, from those studies in which
this could be calculated, is in the small -to – medium
range [36,37], although several studies reported virtually
no change at all, especially in the placebo groups. Very few
studies reported effect sizes above .80 (large effect size per
Cohen [36]).
The baseline pain scores for both types of study group
were in the mild-moderately severe range (3–5 out of 10).
The range of average absolute changes in 100 mm pain
VAS ratings is -5.7 to -11.9 mm over all outcome intervals.
All but two of the studies [41,61] reported change scores
of less than 20 mm. The average relative magnitudes of
change ranged from -8.3% to -25.7%; however, these fig-
ures can be misleading as they do not reflect the variation
in baseline scores ranging from about 30 to 80 mm.
Based on these summaries, and with due regard to the
large confidence intervals for the mean effect sizes, and
with due regard to the small sample in some of the sub-
groups of this study, it appears that the change scores for
chronic neck pain patients not receiving formal therapy
increase relatively little over 4–10 weeks at which point
their increase appears to plateau for up to 12 months. As
well, it appears that the "placebo effect" is not signifi-
cantly different from the effect obtained in unblinded no-
treatment control groups.
Our findings do not appear to bear out the hypothesis that
the changes obtained in the PL groups would be greater
than those in NT control groups. The statistical compari-
sons for all four outcomes (0–10 and 11–52 weeks; mm
and %) were not significant. As noted in the introduction,
the basis for this hypothesis is that the "placebo effect" is
postulated to be stronger than the effect obtained from
mere "trial participation". This expected difference hinges
on the issue of blinding: subjects assigned to no-treatment
control groups become, in short order, aware of this sta-
tus; this awareness is then thought to have a diminishing
effect on their treatment expectations. This, along with the
absence of putatively stronger "placebogenic" effects, is
thought to result in the lowest expected treatment out-
come.
On the other hand, subjects assigned to a placebo group
are, ideally, not aware of this status; their higher treatment
expectations are then thought to contribute to the more
positive placebo "effect"; i.e., a short-term, self-referential
state of improvement which, we had proposed, would be
larger than that obtained in un-blinded, no-treatment
control subjects.
The fact that our findings did not support this expected
effect is, thus, surprising. This is especially so since the
mean PL group baseline pain score was higher than that
of the non-treatment group. One explanation may be that
subjects in the no-treatment control groups, once they rec-
ognize this status, conclude that they will not, or at least
may not, obtain the optimum benefit from their participa-
tion in the study. They may then decide to drop out. If
they remain in the study, they may then decide to seek
additional forms of relief not sanctioned by the study.
These self-relief measures may include increasing the fre-
quency of low-level over-the-counter (OTC) medications
(analgesics, NSAID's, etc.), increasing the use of higher
strength OTC medications, increasing the use of heat or
cold applications, herbal products or other proprietary
procedures, increasing the use of non-professional "treat-
ments" such as casual massage and increasing their use of
exercises, both at home and in one of the many facilities
which have lately sprung up to offer rather sophisticated
exercise protocols (i.e., those with guidance, high quality
equipment, large variety of equipment, pleasant atmos-
phere, etc.).
The use of these sorts of self-treatment measures is by no
means a new phenomenon in the conduct of clinical tri-
als. Trial teams may take a variety of measures to deal with
it, including, explicit attempts to limit it, attempts to
measure it and attempts to incorporate it into their ana-
lytic models. It is likely that trial designers would expect
that such self-help behaviors (self-directed co-interven-
tions) would "wash-out" across all study groups. Our
findings suggest that, at least for chronic neck pain sub-
jects, this may not be so, with the difference possibly aris-
ing from the effect that un-blinded assignment to no-
treatment control status has on the pain management
decisions the subjects so assigned may make during their
participation in the study.
As we did not intend to identify the causal explanation for
the outcomes we obtained, it should be noted that, as
Borghouts et al. [12] and others [3,6,9] have noted, there
are many important prognostic factors in neck pain that
could explain both the treated and non-treated outcomes.
A specific study including some of these factors would be
required to more clearly explain the lack of difference
found between the two groups of studies.BMC Musculoskeletal Disorders 2006, 7:58 http://www.biomedcentral.com/1471-2474/7/58
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Our results are very consistent with two other recent sys-
tematic reviews of placebo-controlled trials [23,24]. Hro-
bartsson and Gotzsche [23] reviewed 29 RCT's of a wide
variety of organic and musculoskeletal pain complaints
and conditions which used placebo analgesia control
groups. They found that the mean effect size of these
groups was 0.27 (range = -1.13 to1.07). Vase et al. [24]
reviewed 23 RCT's of a wide variety of organic and musc-
uloskeletal pain complaints and found a mean effect size
of 0.15 (range = -0.95 to 0.57). Both of these studies con-
cluded that the placebo effect is rather minimal, although
Vase et al. made the point that when the placebo effect is
induced more actively (rather than being used only as a
control procedure), the effects are increased significantly.
Our findings are in agreement with those of Borghouts et
al. [12]. The summary of the outcomes of the control
groups in their review included an average level of
improvement in self-rated pain scores of 14%, an average
level of physician-rated improvement of 18% and an aver-
age level of self-rated "global improvement" of 40%.
Our findings are also in good accord with Farrar et al. [62]
who reported that a 2-point change (30%) in the 11-point
numerical pain rating scale (which is equivalent to 20 mm
change in pain VAS ratings) was regarded as the minimum
clinically important change by patients in a variety of pain
groups. What has not, until now, been systematically
determined is that at least one group of chronic pain sub-
jects – those with neck pain in control groups, and espe-
cially those in placebo groups – does not appear to
improve beyond this level.
While we attempted to obtain the largest possible sample
of high quality studies, it is possible that some English-
language studies were missed. As well, since non-English
studies were not included, it is possible that such studies
may provide different findings. However, the findings
from the studies in our sample were all relatively consist-
ent; it would be surprising to find a separate sample with
greatly different findings.
The findings of our study can be of use to clinical trial
planners by providing a general benchmark of minimum
group mean change scores on pain measures for chronic
mechanical neck pain patients. These findings may also be
of use in the development of clinical guidelines, in that
they provide a benchmark against which the results of
studies of various treatments can be compared. This does
not, however, replace using control groups in future trials,
especially in the early stages of research into a specific
modality of treatment. Where a body of studies does exist,
and where there are no or few well-controlled trials, these
findings may provide a proxy measure for guideline devel-
opers in evaluating the benefit of various treatments.
Conclusion
Our initial question, "what is the expected outcome of
chronic mechanical neck pain patients who are assigned
to control groups?", has been addressed by analyzing two
sets of RCT's providing data on chronic neck pain subjects
in either no-treatment or placebo control groups. It
appears that the changes in pain scores in subjects with
chronic neck pain not due to whiplash who are enrolled
in no-treatment and placebo control groups were simi-
larly small and not significantly different. As well, they do
not appear to increase over longer-term follow-up.
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